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ABSTRACT
Ergosterol is the major sterol found in the membranes of Chlamydomonas
reinhardtii. While past studies have identified some ergosterol mutants in C. reinhardtii,
very little is known about sterol biosynthesis pathways in this species. With the
elucidation of the Chlamydomonas genome, bioinformatics analysis has allowed us to
determine potential genes involved in ergosterol biosynthesis. With this knowledge, a
working model of the pathway was designed for future analysis. Several of the ergosterol
biosynthetic genes were analyzed in respect to their role and involvement in flagellar
regeneration. These genes were upregulated during the regrowth of the flagella. Also
Chlamydomonas strains lacking flagella were analyzed by Q-RT PCR to determine what
role ergosterol biosynthetic genes played in the absence of their flagella. Finally, one of
the genes with homology to the yeast sterol C-5 desaturase, ERG3, was chosen for further
analysis. To test whether ERG3 of C. reinhardtii had a similar function, yeast
Saccharomyces cerevisiae ERG3 knockout strains were created to assess whether a
plasmid expressing the Chlamydomonas ERG3 could complement the deletion. These
erg3 null mutants were transformed with a vector expressing ERG3 cDNA from C.
reinhardtii driven by the yeast ADH1 promoter, and this expression was able to restore
ergosterol biosynthesis and reverse phenotypes associated with lack of ERG3 function.
Complementation of these erg3 null phenotypes strongly suggests that ERG3 in C.
reinhardtii functions as a sterol C-5 desaturase. Results from this dissertation provides
the groundwork for future experimentation in the field of sterol lipid research in
Chlamydomonas reinhardtii.
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CHAPTER 1
REVIEW OF LITERATURE
1.1 Overview of Sterol Lipids
Sterols are lipid-soluble molecules containing a four-ring structure with a 3βhydroxyl group and an aliphatic side chain of 8 or more carbon atoms. Sterols fall under
the macromolecule class of lipids. They are resistant to saponification, and are found in
abundant quantities in all animal and plant tissues. The physiology and viability of
eukaryotic cells depends on the presence or absence of sterols. Therefore, there is great
variation between the classes of sterols in specific cell types as well as species. The
major differences in sterols include the number, location and orientation of double bonds
and side chains (Fahy et al., 2005). The nomenclature of sterols is basically defined and
based upon the “tetracyclic skeleton” as seen in Figure 1.1 (Moore, 1993). The
tetracyclic skeleton is composed of carbons 1-27 while carbons 28, 29, 30, 31, and 32, are
subsequently added to the molecule (Fahy et al., 2005). In the sterol nucleus, the up
conformation is referred to as β while the down conformation is α. The conformational
orientation of the side chain is the exact opposite, as the up conformation is denoted as α,
while the down conformation is described as β (Fahy et al., 2005). For example, the
major differences associated with algal, plant and fungal sterol lipids have a great deal to
do with variations in the side chains (Moore, 1993). Lanosterol, an ergosterol precursor
in yeast produces sterols in the S configuration, while in plants, cycloartenol is the
precursor, and its sterol products are found in the R configuration (Moore, 1993).
Understanding this complex nomenclature system is integral for proper identification of
sterol lipids in Chlamydomonas reinhardtii.
1

Figure 1.1 Sterol nomenclature. Each ring is denoted as either A, B, C, or D. ∆ with a
superscript number denotes the location of a double bond from that carbon to the carbon
with the next higher number. Double bonds between carbons can also be indicated by the
carbon with the lower number followed by the carbon with the higher number, the latter
in parentheses. The position of a carbon in the molecule is indicated by C- followed by a
number. C with a subscript number explains the total number of carbons in the molecule.
Picture adopted from reference (Moore, 1993).
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While naming sterol lipids and understanding their phylogenetic differences have
been very important aspects of lipid biochemistry, the function of lipids and sterols has
been an even more intriguing field of study. Lipids are a major component of cell
membranes. Membranes are dynamically changing entities that possess not only lipids
but proteins as well. The Singer-Nicholson fluid mosaic membrane model proposed that
there are random components of the membrane that allow for indiscriminate rotational
freedom of molecules (Singer, 1972, Singer & Nicolson, 1972). After years of research,
scientists have been able to refine this model. It is now thought that this random
movement of molecules is in actuality very unambiguous. Scientists argue that there
needs to be a paradigm shift from the previous Singer-Nicholson model to a more
updated model incorporating membrane microdomains. There are six characteristics of
cell membranes that do not fit with the Singer-Nicholson model: (i) specific patterns of
distribution for receptors in the plasma membrane, (ii) lipid associations with signaling
molecules, (iii) unrestricted diffusion of particles through a shorter diffusion barrier, (iv)
lipids associate with specific membrane proteins, (v) presence of integral proteins
maintain membrane domains, (vi) protein reorganization to allow for protein-protein and
lipid-protein interactions (Vereb et al., 2003). These physical characteristics of the
membrane enhance the previous model of a more random unorganized, description of
lipids and proteins as described by Singer and Nicholson. The movement of lipids and
proteins in the membrane are far from unrestricted.
Membranes are essential components of eukaryotic cell function. The plasma
membrane is particularly significant since it separates the inner compartments of the cell
from the outside environment. Sterols are important lipid components of the plasma
membrane, and have been shown to play crucial roles in several cellular functions.
3

Detailed studies of sterols have focused primarily on understanding how sterols influence
membrane fluidity and permeability. The effects of sterols on the activity of membrane
bound enzymes and rates of cell growth have also been of significant interest.
1.2 Physiological Role of Sterols
As vital components of the plasma membrane, sterols play a critical role in
maintaining the structure and viability of the cell. The primary biophysical role of sterols
is to maintain the spacing between phospholipid molecules of the membrane bilayer in
order to restrict van der Waals forces (Figure 1.2). Homeostasis is best maintained in the
cell when the membrane is functioning at an optimal fluidity. At high temperatures,
lipids can weaken and become too fluid-like, while at lower temperatures, the lipid
bilayer can become too rigid and solidify. The presence of sterols prevents solidification
at lower temperatures and melting or weakening of the membrane at higher temperatures.
While this is not the only physiological role of sterols, this phenomenon has been quite
intriguing to the scientific community. Maintenance of the membrane fluidity continues
to be a well-defined role of sterols (Solomon et al., 2008).
One prominent sterol found in the membranes of many fungal species is
ergosterol, which is the primary sterol lipid in Sacchromyces cerevisiae (Daum et al.,
1998). The post-squalene biosynthesis of ergosterol in yeast has been well defined
(Arthington-Skaggs et al., 1996, Osumi et al., 1978). Enzymes of the ergosterol
biosynthetic pathway have been found to be major targets for drug interactions (Balliano
et al., 1989, Rao & Grollman, 1967, Siegel & Sisler, 1965, Cohen & Eaton, 1979), as
many modern antifungal drugs on the market were derived specifically to target
ergosterol biosynthesis (Cowen & Steinbach, 2008, White et al., 1998). For example,
azole drugs directly affect ERG11, a cytochrome p450 family protein, which is
4

Figure 1.2 Schematic Diagram of the Phospholipid Bilayer. (A) Phospholipid bilayer
with an integral membrane protein. (B) Phospholipid bilayer with an integral membrane
protein embedded with sterol molecules to increase the spacing and maintain fluidity of
the bilayer. This figure was adapted from the original Singer-Nicholson model (Singer,
1972, Singer & Nicolson, 1972).
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responsible for converting lanosterol to 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol
(Aoyama et al., 1981, Parks et al., 1995, Kalb et al., 1987, Barrett-Bee & Dixon, 1995).
Overall, ergosterol plays a very important role in other lipid biosynthetic
pathways. Several processes in phospholipid biosynthesis are regulated by ergosterol.
Phospholipid composition is affected by the transfer rate of phospholipids by
phosphotidylinositol-transfer protein when stimulated by ergosterol (Szolderits et al.,
1989). Ergosterol is known to upregulate the activity of phosphatidylinositol kinase,
(Dahl et al., 1987, Dahl & Dahl, 1985) and the methylation of phosphatidylethanolamine
to phosphatidylcholine is also stimulated by ergosterol (Kawasaki et al., 1985). In
addition, evidence exists for crosstalk between ergosterol and other lipid metabolic
pathways. Ceramide production is down-regulated when 3-hydroxy-3-methylgutarylCoA reductase, a critical enzyme in ergosterol biosynthesis, is inhibited by lovastatin in
mammalian cells (Storey et al., 1998). Microarray analysis has shown that expression of
genes involved in long chain fatty acid synthesis is significantly affected when ergosterol
biosynthesis is blocked (Bammert & Fostel, 2000).
Specific lipids are responsible for increasing the order and organization of
membrane domains. These unique proteins and lipids organize to form lipid rafts. In
vertebrates, three specific lipids act as major precursors to the lipid raft: sphingolipids,
phospholipids and cholesterol, the structures of which are depicted in Figure 1.3. Lipid
rafts have roles in cell signaling, protein synthesis, cell cycle regulation, and
phosphorylation of different regulatory kinases (Simons & Toomre, 2000). The outer
leaflet of rafts is normally comprised of glycosphingolipids and sphingomyelin, while the
inner leaflet contains glycerolipids with fatty acyl chains. In vertebrates, cholesterol is a
major component of the lipid rafts (Brown & London, 1998). Cholesterol is extremely
6

Figure 1.3 Three major molecules involved in lipid raft formation. (A) cholesterol;
(B) phospholipid; (C) sphingolipid.
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rigid due to its four ring structure, and thereby functions to increase the fluidity of the
membrane by thermodynamically reacting with other lipids to change the gel phase to a
liquid ordered phase. With cholesterol present, the membrane is inhibited from moving
into the crystalline state. Cholesterol buries itself between the hydrocarbon tails of the
sphingolipds, and in its absence lipid rafts lose all integrity and may fall apart (Simons &
Toomre, 2000). The Golgi apparatus is thought to be the organelle in cells in which lipid
rafts are assembled (Brown & London, 1998). After synthesis of cholesterol and
sphingolipids in the endoplasmic reticulum these molecules are then moved to the Golgi
for lipid raft assembly (van Meer, 1989). In recent years, researchers have been able to
identify the lifetime of lipid rafts in the cell. It was previously thought that these
microdomains were very stable, but now information has become available indicating
that lipid rafts are short-lived in the cell, perhaps existing for only “tens of seconds”
(Edidin, 2001). In general, rafts are relatively small in size in order to maintain “raftborne signaling proteins” in a state of inactivity (Simons & Ehehalt, 2002). When
activated, rafts assemble into larger platforms by which functionally related proteins can
then interact and crosstalk (Simons & Ehehalt, 2002). There are several diseases that are
related to defects in assembly of lipid rafts. Those include Alzheimer’s disease,
Parkinson’s disease, diabetes, and osteoarthritis (Simons & Ehehalt, 2002). Lipid rafts
are extremely important for maintaining the viability of an organism. It is thought that
changing cholesterol levels in the cell can affect the “association pattern” of lipid rafts
(Matko & Szollosi, 2002). Cellular uptake of cholesterol can affect transcriptional
regulation of genes involved in the pathway as well as the ability to properly cluster and
assemble rafts (Tall et al., 2002).
8

1.3 Overview of Sterol Biosynthesis
Two major pathways for sterol biosynthesis have been found in eukaryotes.
Fungi and vertebrates synthesize sterols with lanosterol as an intermediate, while plants
synthesize sterols using cycloartenol as an intermediate. In these pathways the
biosynthetic steps from isopentanyl PP (IPP) to squalene epoxide are the same.
However, the cyclization of squalene epoxide is where the two pathways diverge
producing either cycloartenol or lanosterol. (Figure 1.4). Less is known about the
biosynthesis of sterols in algal species. Red algae, green algae and diatoms are thought to
make cycloartenol while dinoflagellates have been reported to make lanosterol (Baker &
Kerr, 1993, Giner, 1993).
There is a some evolutionary difference between sterols found in mammals, fungi,
higher plants, algae, and some protozoans (Bloch, 1983). There are significant structural
differences between cholesterol and ergosterol, the central sterols of eukaryotic
organisms (Figure 1.5). Ergosterol has two double bonds at C-7 and C-22 and a side
chain methyl group at C-24. It has been suggested that cholesterol is found in
mammalian cells because of its ability to function in the optimization of membrane lipid
packing for the purpose of maintaining rigidity and fluidity dependent on temperature and
cell size (Bloch, 1983, Arora et al., 2004), while ergosterol is favored in lower eukaryotic
species to enhance membrane disorder as a substitute for the production of unsaturated
fatty acids (Bloch, 1983).
1.4 Sterols in Eukaryotic Organisms
Sterols are found in the membranes of most eukaryotic organisms (Bloch, 1983).
Even though there are similarities, the differences between mammalian, fungal and plant
sterols are quite distinct. The major sterol found in mammalian cell plasma membranes
9

Figure 1.4 Schematic diagram showing the evolutionary branch from IPP to
lanosterol and cycloartenol.
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Figure 1.5 Diagrams of the structures of cholesterol and ergosterol.
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is cholesterol, which is an intermediate in the synthesis of Vitamin D, bile salts and
hormones. Plant cells contain sitosterol, while fungal cell membranes have ergosterol as
the major sterol components (Bloch, 1983). Plants have a variety of sterols including
sitosterol, 24-methyl cholesterol and stigmasterol (Benveniste, 2004). Ergosterol is also
found in the membranes of protozoan parasites, Leishmania and Trypanosoma (Mbongo
et al., 1998), and interestingly, the eukaryotic model system, Drosophila melanogaster,
where it is a major sterol lipid (Rietveld et al., 1999).
While the study of sterol biosynthesis in eukaryotic organisms has looked
primarily at the functional role of sterols in terms of end-product sterol formation,
scientists have also examined the production of sterols not as strict precursors but also as
hormonal regulators as well (Norton & Nes, 1991). In mammalian cells, cholesterol
serves as the precursor to the hormonal regulators, testosterone and estrogen. Like
testosterone and estrogen, brassinosteroids in higher plants act as sterol hormones to
coordinate several cellular processes (Bajguz, 2007). To date, no steroidal hormones
have been identified in C. reinhardtii. However, in another algal species, Prototheca
wickerhamii, two new steroidal triene hormones have been identified (Norton & Nes,
1991). Interestingly, a great deal of research has also been done to elucidate specific
steps in ergosterol biosynthesis by which pathogenic organisms like Trypanosoma brucei
might be eradicated. Scientists have shown that the import of cholesterol in this model
system does not diminish ergosterol biosynthesis or the hormonal importance of the
molecule in T. brucei, but introducing an analog of the sterol C-24 methyltransferase
does effectively stop the growth of the organism in the bloodstream (Zhou et al., 2007).
This is just one example of how sterols play multiple roles in the cell across several
different eukaryotic species, and how an understanding of their synthetic pathways may
12

be exploited for therapeutic purposes.
1.5 Isoprenoid Pathway
Isoprenoid synthesis has been studied since the late 1950s and has given great
insight into the biochemical process in photosynthetic higher plants and algae. Sterols are
a direct end product of isoprenoid biosynthesis. For many years there has been a debate
about whether or not there are two distinct pathways for the synthesis of isopentenyl
diphosphate (IPP). It is thought that IPP serves as the common C5 precursor that aids in
the production of most isoprenoids including sterols.
3 Acetyl- CoA

Mevalonate

IPP

OR
Pyruvate
1-deoxy-d-xylulose-5-phosphate

IPP

GAP
Figure 1.6 The classical formation of Δ3 –isopentenyl diphosphate (IPP) by the
acetate/mevalonate pathway and the alternative 1-deoxy-d-xylulose-5-phosphate
(DOXP) pathway. Chlamydomonas reinhardtii uses the DOXP pathway to synthesize
sterols in the cell.
By radioactive incorporation experiments, it has been shown that C. reinhardtii, uses a
mevalonate independent pathway to synthesize its sterol molecules (Lichtenthaler, 1999).
IPP is generated by the DOXP pathway as seen in Figure 1.6 (Schwender et al., 1999).
By labeling 1-deoxy-d-xylulose-5-phosphate, it has been discovered that incorporation of
the molecule was found in the isoprene units of C. reinhardtii (Steele et al., 1969).
From an evolutionary perspective, the DOXP pathway is distributed among
13

photosynthetic algae and higher plants. Euglena appear to have lost the DOXP pathway
for the synthesis of IPP (Lichtenthaler, 1999, Van Den Hoek, 1997). They rely solely on
the mevalonic acid pathway for the production of isoprenoid products, whereas green
algae such as C. reinhardtii have been able to utilize the DOXP pathway for sterol
synthesis (Steele et al., 1969). It is also maintained that in Arabidopsis and C.
reinhardtii, DOXP synthase possesses a signal peptide sequence implying its localization
for the pathway in the plastids (Mandel et al., 1996). Isoprenoid synthesis has been
known to take place in the chloroplasts (Lichtenthaler et al., 1997, Moore, 1993).
Cyanobacteria use the DOXP pathway and are thought to be the “progenitors of the
chloroplast,” but through the co-evolutionary process with eukaryotes, the DOXP process
was compartmentalized in higher plants (Mandel et al., 1996, Nicolson & Singer, 1972).
In conclusion, the early studies in isoprenoid biosynthesis demonstrated the
diverse nature of algal, fungal and higher plant metabolic pathways. Chlamydomonas
reinhardtii utilizes the DOXP pathway for the production of isoprenoids. Future work in
this area will be of utmost importance for characterizing the genes and enzymes that
coordinate the synthesis of isoprenoids and precursors to sterols in the membrane of this
model system.
1.6 S. cerevisiae as a Model Organism for Study of Ergosterol Biosynthesis
Much like cholesterol biosynthesis, ergosterol synthesis has been widely studied.
The yeast, Sacchromyces cerevisiae, has been used as a model system for the study of
this membrane component. Many antifungal agents have been created to target the
enzymes of ergosterol synthesis, thus killing the fungal organism. The ergosterol
pathway is catalyzed by at least eleven enzymes (Figure 1.7). These enzymes perform a
series of biochemical steps to change the unsaturated, linear squalene structure to the four
14

ring sterol, ergosterol. The chemical name for ergosterol is 24β -methylcholesta-5,7,22triene- 3β-ol. Scientists are able to grow cultures of S. cerevisiae at a relatively low cost
and manipulate genes of the ergosterol biosynthetic pathway in order to better identify
the function of each enzyme (Daum et al., 1998, Parks & Casey, 1995). There is a yeast
knockout library that is commercially available. Ergosterol biosynthetic genes have been
deleted and their phenotypes are well catalogued and documented
(http://www.yeastgenome.org). As with C. reinhardtii, the entire genome of S. cerevisiae
is sequenced and available for analysis. The yeast genome contains a total chromosomal
sequence of approximately 12 Mb with a haploid set of 16 chromosomes that range in
sizes as small as 200 kb to 2,200 kb (Sherman et al., 2002). The sequence, released in
1996, identified 6,183 possible ORFs encoding proteins greater than 100 amino acid long
(Sherman et al., 2002). Functional complementation of ergosterol biosynthetic genes in
yeast can be performed with great efficiency (Rothstein, 1983, Parks et al., 1999). In
addition, yeast also serves as a great model system for other molecular biology
experimental approaches such as two hybrid analysis and serial analysis of gene
expression (SAGE) (Sherman et al., 2002).
1.7 C. reinhardtii as a Model Organism for Study of Ergosterol Biosynthesis
C. reinhardtii has been well defined as a model organism for biochemical and
molecular studies. Historically, the organism has been manipulated for analysis of
photosynthesis, light perception, cell cycle control, flagellar and basal body structure and
function, as well as chloroplast biogenesis (Harris, 2001, Rochaix, 1995). The organism
is both unicellular and eukaryotic, and it can be grown photosynthetically, or in the
presence of a carbon source such as acetate. There are two mating types (mt+ and mt-)
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Figure 1.7 The Ergosterol Pathway in S. cerevisiae. The schematic diagram shows the
reactants, enzymes and precursors to ergosterol in yeast.
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that can be easily crossed for genetic studies. The nuclear, chloroplast and mitochondrial
genomes have well defined markers for efficient transformation and genetic manipulation
(Boynton et al., 1988, Kindle, 1990, Dunahay, 1993, Shimogawara et al., 1998). Mutant
stocks and DNA clones are readily available for analysis
(http://www.yale.edu/rosenbaum/ chlamy_resources.html). EST clones and genomic
sequences are released and updated on a one to two year basis. There have been four
versions of the Chlamydomonas genome released
(http://www.biology.duke.edu/chlamy_genome/index.html, http://genome.jgipsf.org/Chlre4/Chlre4.home.html). The genome size is estimated to be approximately
1x108 base pairs (Harris, 2001, Rochaix, 1995). There is a codon bias that favors a high
GC content, and upstream of these GC rich sequences there are adenosine rich elements
(Rochaix, 1995). On average each gene contains approximately four intron regions of
219 bases within a kilobase of coding sequence, allowing the number of introns to be
approximately equal to that of the coding region (Lefebvre & Silflow, 1999).
1.8 Sterol Biosynthesis in C. reinhardtii
Chlamydomonas reinhardtii is a unicellular alga that has great potential as a
model system for lipid and membrane studies (Harris, 2001). Lipids play significant
roles in the integrity and functioning of the plasma membrane as well as organelle
membranes. Sterols are a major component of many membranes, including those found
in algae.
Flagellar membranes have been studied extensively. In Chlamydomonas, the
flagellar membrane seems to be somewhat different from that of the whole cell. Prior
research has shown that the flagellar membrane is not a continuation of the plasma
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membrane, but is quite unique in its components (Gealt et al., 1981). Gealt showed that
in whole cell extracts 14:0, 16:0, 16:2, 16:3, 18:0, 18:1, 18:2 and 18:3 fatty acids, while
flagella extracts only contained 16:0, 18:0, 18:1, 18:2 and 18:3 fatty acids. He also
showed that ergosterol and 7-dehydroporiferasterol were the two major sterols of the
flagellar membranes in C. reinhardtii. The sterol composition of the membrane was
reported to be 55% ergosterol while 45% was 7-dehydroporiferasterol (Gealt et al.,
1981). To further study the function of sterols in this model system, Janero et al. looked
at variations in sterol synthesis during different phases of the cell cycle (Janero et al.,
1982). He reported high rates of sterol synthesis in mid to late G1 phase of the cell cycle
or the light period, while it drops dramatically during the dark period.
In addition to lipids, proteins also are a major component of the membranes.
Several proteins are contained in the two posterior flagella of C. reinhardtii, but one
major protein is thought to be dominant in the flagellar membrane (Nakamura et al.,
1996, Snell, 1976). This mastigoneme protein (Figure 1.8) extends from the outer
membrane of the flagella into the surrounding medium. These proteins function to
increase swimming velocity as well as serving to anchor the cells together during the
mating process (Witman et al., 1972). The mechanism by which this protein reaches the
tip of the flagella has not been elucidated.
Reflagellation is a naturally occurring phenomena in C. reinhardtii, allowing the
flagella to regenerate after excision or pH shock (Harris, 2001). Intraflagellar transport
(IFT) is a microtubule-dependent motility process that was first observed in the lab of
Joel Rosenbaum at Yale University by Keith Kozminski (Kozminski et al., 1993,
Sloboda, 2002). This process occurs in an anterograde fashion by which soluble protein
particles are moved from the cell body to the tip of the flagellum or cilium and back to
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the cell body (Rosenbaum & Witman, 2002). IFT rafts, unlike lipid rafts, do not contain
lipids but do occur within the cilia or flagella beneath the plasma membrane (Sloboda,
2002, Silflow & Lefebvre, 2001).

Mastigonemes

Figure 1.8 TEM pictures of isolated flagella with the intact membrane after pH
shock. Mastigonemes are the smaller structures extending off of the sides of the flagella.
But like lipid rafts they too play a role in human disease. One of the first connections
between IFT and human disease was established with the characterization of IFT
complex A and B polypeptides from C. reinhardtii (Pazour et al., 2000, Pazour et al.,
1999). Experimental evidence demonstrates that IFT particles are required for
reflagellation as well as proper development of cilia (Pazour et al., 2000, Pazour et al.,
1999). Defects in IFT result in polycystic kidney disease (Pazour et al., 2000, Pazour et
al., 1999).
1.9 Goal of This Dissertation
The goal of this dissertation is to elucidate sterol biosynthesis in C. reinhardtii.
While, sterol biosynthesis in Chlamydomonas has not been studied much since the late
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1990s, I truly hope that by characterizing the genes of the biosynthetic pathway and
providing experimental data supporting evidence of this pathway, the scientific
community will be excited about new pursuits in the area of lipids research. Ergosterol
biosynthesis overlaps with many metabolic pathways, and it is of particular interest to
also show interactions between ergosterol biosynthesis and reflagellation. The overall
objectives of this work are the following: (1) to identify these biosynthetic genes for
future studies of biodiesel alternative fuel production and (2) find the link between sterols
and the ability to regenerate flagella and cilia.
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CHAPTER 2
MATERIALS AND METHODS

2.1 S. cerevisiae Strains and Growth
Yeast strains were constructed by homologous recombination using primers
5’- TGC ATT TGT AAA AAA AGA TAA AA GAA AAA TAT TCG TCT AGA TTT
GAG ATG CAG ATT GTA CTG AGA GTG C- 3’ (forward) and 5’- TCT TGA ACG
TGA AAG AAA GAA AAA AGA TGA GAC AAA CAA GGC AAC CGT ATC TCC
TTA CGC ATC TGT GCG G-3’ (reverse) to amplify the yeast URA3 gene flanked by
ERG3 sequence. Deletion of ERG3 was done in a diploid strain DDY2 (a diploid version
of S. cerevisiae W303), which was then sporulated to produce haploid cells (see below).
Yeast were cultured in YPD (1% yeast extract, 2% peptone, 2% dextrose) or YMD
(synthetic minimal medium, 2% dextrose, U. S. Biologicals catalog # Y2025)
supplemented with required amino acids and nucleotides (Sherman, 1991). Unless
otherwise stated, all yeast operations were carried out according to standard procedures
(Guthrie & Fink, 1991). To construct an ADH1 promoter vector, the plasmid pOAD used
(Dr. Stan Fields, University of Washington) was modified as follows. The GAL4 coding
sequence was removed by digestion with Hind III, and re-ligated to produce the ADH1
promoter control vector pDD1193, and ERG3 genes were cloned into the resulting unique
Hind III site. Expression of S. cerevisiae and C. reinhardtii ERG3 cDNA from the ADH1
promoter of yeast expression vector pDD1193 was carried out by culture of the
transformed yeast strain in YMD lacking leucine.
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2.2 Yeast Competent Cell Preparation and Transformation
Single yeast colonies were inoculated and grown overnight. The following the
morning, cultures were diluted to an optical density of 0.2 (A600), and cells were grown
until reaching an approximate optical density of 0.7. Cells were harvested by
centrifugation (2000xg for 5 minutes) at room temperature, and the cell pellet was
resuspended in 1 mL of 1xTEL (10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 8.0, 100 mM
LiAc) per 10 mL culture volume and rocked overnight at room temperature. Yeast were
transformed with plasmids using the protocol of Geitz et al (Gietz & Woods, 2002).
2.3 Yeast Genomic DNA Extraction
Yeast genomic DNA was extracted by the Winston protocol (Hoffman & Winston, 1987).
2.4 Tetrad Dissection
Heterozygous diploid cells were cultured on YPD plates, then transferred to spore
plates. A 1mm mass of cells was resuspended in 6µL Zymolase (1mg/mL) for each
sporulation and incubated for 2 minutes at room temperature. After incubation, 300µL of
water was added to each sample. Each sample solution was then spread along the upper
portion of a petri dish and tetrads were separated with an Olympus B201 Dissecting
scope. Each plate was incubated at 30º C, and cells were re-patched to a master plate.
Each master plate was then replica plated to YMD dropout plates and mating tester lawns
to determine genotype.
2.5 C. reinhardtii Strains and Growth
Dr. R. K. Togasaki of Indiana University, Bloomington provided Wild type C.
reinhardtii 137+. Rogene Schnell, University of Arkansas-Little Rock, provided strain
D66 (nit2 , cw15, mt ). Strains cc477,cc478, cc479,cc480, cc482 and cc652 were ordered
-

+

from the Chlamydomonas Culture Collection. Cultures were grown on Tris Acetate
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Phosphate (Sueoka, 1960) (TAP) medium plates. They were inoculated into 100 mL of
TAP medium (Sueoka, 1960) and set to grow with continuous light (300 µE m-2S-1) and
shaking for 2-3 days. Aliquots of the culture were transferred to a larger flask (Sueoka,
1960) or carboy and bubbled with high CO (5% CO in air) for several days. Cells were
2

2

then collected for further analysis: pH shock or RNA preparation.
2.6 Chlamydomonas Core Library
The Chlamydomonas cDNA core library was purchased from the
Chlamydomonas Center (http://www.chlamy.org/). The library was amplified using the
host strain XL1 Blue MRF’ (Stratagene catalog number 200301) according to the
manufacturer’s instructions at http://www.stratagene.com/lit/manuals/aspx (catalog
number 236201).
2.7 cDNA Cloning
The S. cerevisiae ERG3 protein coding sequence (accession number NP_013157)
was used to identify the C. reinhardtii EST with the best homology using the BLAST
server (http://genomeportal.jgi-psf.org/Chlre4/Chlre4.home.html). Primers were
designed based on the EST sequence in order to clone the coding region of cDNA from
the core library described above. The primers used to clone the cDNA by PCR included
the forward primer 5′-GCG GCC GCC GAT CGA AGC TTA ATG TCA ACC TCG
CTC AAA ATG A-3′and the reverse primer 5′-GCG GCC GCC GAT CGA AGC TTT
ACT GCG CCT TGA CGG CCT T -3′.
2.8 Bioinformatics and Sequence Analysis
Information about genes found in Chlamydomonas was gathered from searching
the genomic database, which yielded gene models, scaffold and chromosome locations
(http://genome.jgi-psf.org/Chlre4/Chlre4.home.html). Ergosterol biosynthetic enzymes
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were obtained from Sacchromyces cerevisiae sequences on the NCBI protein database.
The C. reinhardtii EST database using the BLAST program provided alignments with the
yeast amino acid sequences (http://www.ncbi.nlm.nih.gov/BLAST) (Altschul et al.,
1997). In order to determine the correct gene, E-values were considered. The gene with
the smallest E-value assignment was chosen as the best choice for the gene. E-values are
often used to differentiate between multiple copies of the same gene in the genome. The
E-value is a statistical value that estimates the probability of similarity between a given
sequence and the database of sequences. Splice sites of the exon/intron and open reading
frames were identified by the method described by Silflow in 1995 (Silflow et al., 1995).
ChlorP, TargetP, and SortP were used in generating data for protein prediction. These
programs included hyperlinks to the Expasy server (http://ca.expasy.org/tools/#translate).
The Pfam database was used to identify possible domains in the protein sequences
(http://pfam.sanger.ac.uk). ClustalW sequence alignment provided similarities in protein
sequence (http://www.ebi.ac.uk/Tools/clustalw2/). PSORT (Prediction of Protein Sorting
Signals and Localization Sites in Amino Acid Sequences) was used to predict the
localization of specific proteins (http://psort.nibb.ac.jp/). The Saccharomyces genome
database provided information about the function of the enzymes in yeast
(http://www.yeastgenome.org/). Multiple sequence alignment programs from the
European Bioinfomatics Institute EMBL-EBI server (http://www.ebi.ac.uk/clustalw/)
were used for sequence analysis and alignment data. The Prosite database from EBI
server (http://ca.expasy.org/prosite/) was used to identify putative consensus motifs for
specific domains. The C. reinhardtii genomic database provided information about the
genomic sequence, intron-exon structure, as well as information regarding potential
membrane spanning regions of the protein coding sequence (http://genomeportal.jgi24

psf.org/Chlre4/Chlre4.home.html).
2.9 Drug Resistance Screen
Cycloheximide was purchased from Sigma Aldrich (catalog# C- 7698-1G). S.
cerevisiae minimal medium was prepared as previously described with the addition of
cycloheximide (Dudley et al., 2005) at a final concentration of 0.13 µg/mL from a stock
solution of 2mg/ml in 100% ethanol.
2.10 Lipid Extraction
Yeast cells were grown to an optical density at A600 of 0.7-0.8. The cells were
precipitated at 2000 rpm for 5 minutes and resuspended in 4mL hot isopropanol (70º C)
for 30 minutes. The cell wall was disrupted by vortexing with 0.5mm glass beads for 2
minutes. Cell pellets were then resuspended in 4mL hot isopropanol and lipids were
extracted at 70º C for 2 hours. Next, 4mL of chloroform/methanol (1:2) and 2mL of 1 M
KCL were added to the lipid extracts, which were vortexed and centrifuged at 5000 rpm
on a benchtop centrifuge for 5 minutes. The top aqueous phase was discarded and the
previous extraction step was repeated three times. Then, 2mL of water were then added
to the samples. The samples were vortexed and centrifuged at 5000 rpm for 5 minutes,
and the aqueous phase was discarded again. Lipids were dried under nitrogen and stored
at -80º C. The lipid extraction protocol was derived from the Bligh and Dyer method
(Bligh & Dyer, 1959).
2.11 GC/MS Analysis
Ergosterol standard was purchased from Fluka. N,O-bis(trimethylsilyl)
trifluoroacetamide (BSTFA) was used as the silylating reagent and was purchased from
Sigma Aldrich (catalog #33084). 100µL of BSTFA was added to dried lipid samples and
heated to 60º C for 30 minutes. Derivatized samples were resuspended in 25µL of
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dichloromethane and prepared for analysis. GC/MS was carried out on an Agilent 6890
gas chromatograph with an autosampler and Agilent 5973 mass selective detector. Then,
1µL of sample was injected into a splitless system with a flow rate of 1mL/ min for the
carrier gas, helium. The front inlet temperature was maintained at 250º C, while the mass
selective detector line heater was at 280º C. The oven temperature was programmed to a
final temperature of 300º C with an initial temperature of 100º C. The GC column, DB5ms, was 30 meters by 250 µm of internal diameter with a film thickness of 0.25 µm.
Data were acquired by selective ion monitoring to detect ions at m/z 143, 211,337, 363,
468.
2.12 Flagellar pH Shock
Chlamydomonas reinhardtii wt 137 mt- cultures were grown on Tris-Acetate
Phosphate (TAP) agar plates, and aseptically inoculated after 5 days into Tris-Acetate
Phosphate media for 2 days with continuous shaking under light. TAP cultures were
transferred to Minimal media (MIN) and incubated at 30ºC for 48 hours under continuous
light and CO2 with continuous shaking. Cultures were harvested by centrifugation in a
Beckman J2-21 centrifuge at 4ºC, 480g for 10 minutes in a JA-10 rotor. The original
MIN medium was saved for resuspension of cells prior to flagellar regeneration analysis.
The cell pellet was resuspended as a control in 30mL of the original MIN medium and
incubated at 30ºC on a shaker under light.
Acid shock for removal of flagella: The pellet was resuspended in 50mL of
10mM Tris-HCl buffer, pH 7.8 + 7% sucrose (w/v) at 4ºC. Cells were deflagellated by
addition of 0.5N acetic acid to pH 4.5 and held at acid pH for 45 seconds, following
which the pH was raised to 7.8 with 0.5N KOH (10). 15mL aliquots of the shocked cells
were under-layered with 20mL aliquots of 10mM Tris-HCl buffer, pH 7.8 at 4ºC + 25%
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sucrose (w/v) and centrifuged in a Beckman J2-21 centrifuge at 4°C with a JA-20 rotor
for 11 minutes at 2000g. The 7% sucrose layer and interface was removed and flagella
were purified by centrifugation at 27,000g.
2.13 Total RNA Isolation
Trizol reagent (Invitrogen, Carlsbad, CA) was used to extract RNA from C.
reinhardtii. Cells were harvested and transferred to 50 ml conical centrifuge tubes. Cells
were then spun at 3000 rpm for 5 minutes at a final temperature of 4°C. The pellet was
resuspended and transferred to 1.5 mL Eppendorf tube with one mL of Trizol. Cells were
then vortexed and left to incubate for one hour at room temperature. After the duration of
the hour 200 µL of chloroform was added. To mix the sample, the tubes were again
vortexed and incubated at room temperature for 5 minutes. The samples were
centrifuged at 10,000 rpm for 15 minutes at 4°C.
The aqueous phase of approximately 600 µL was removed and transferred into a
fresh 1.5 mL Eppendorf tube. 0.5 mL of isopropanol was added and the samples were
again incubated for 30 minutes. The samples were centrifuged at 10,000 rpm for 15 min
at 4°C. The supernatant was removed, and the RNA pellet was washed with 1.0 mL 75%
ethanol and then centrifuged at 8,000 rpm for 5 min. The supernatant was removed and
the pellet was air dried for an hour. The RNA was finally treated with Ambion Turbo
Dnase. The manufacturer’s protocol was followed and the samples were then treated by
an RNA clean-up using Qiagen’s RNeasy Clean-up Kit. Total RNA concentration was
calculated by absorbance at 260 nm, using the conversion equation: 1 OD260 = 44 µg of
RNA•mL-1.
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2.14 Quantitative RT (Real Time) PCR
3µg of total RNA was used as template for synthesis of cDNA. Transcriptor First
Strand cDNA Synthesis Kit (Roche, Indianapolis, IN) was used to synthesize the cDNA
according to manufacturer’s instruction. An aliquot of one-tenth synthesized cDNA was
used as the template with Takara Bio Sybr Green Premix Ex Mix (Takara-Bio, Madison,
WI) for quantitative PCR in an ABI Prism 7000 sequence detection system following the
manufacturer’s instructions (Applied Biosystems, Foster City, CA).
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CHAPTER 3
BIOINFORMATIC ANALYSIS OF ERGOSTEROL BIOSYNTHESIS
IN C. REINHARDTII

3.1 Introduction
In the new age of bioinformatics, scientists are faced with an interesting
conundrum. We now have access to sequences for countless numbers of potential genes
without ever testing their functions in the cell. The Basic Local Alignment Search Tool
(BLAST) has become such an integral tool for analysis, we as scientist often forget that
very few experiments have actually been done to elucidate and characterize these genes.
The original papers (Altschul et al., 1997, Altschul et al., 1990) describing BLAST
continue to be some of the most cited scientific literature articles (Geer, 2006). Many of
the algorithms used with the original BLAST have been implemented on several genome
websites to enhance the search for potential genes of interest (Geer, 2006).
Although this vast sea of information is available with very little characterization,
it does provide a multitude of benefits that are enhancing research. For example, BLAST
alignment gives greater identification of possible relationships between different species
and genes, allowing for greater efficiency in the design of experiments. Also, the cost
effectiveness of the BLAST program allows science to move at lightning speed (Geer,
2006). One cannot truly grasp the efficiency of how this program has enhanced research
until we look at the breadth of just one research topic such as ergosterol biosynthesis. In
1978, the first sterol mutants in C. reinhardtii were isolated by selecting for single
colonies resistant to nystatin (Bard et al., 1978, Salimova et al., 1999). In 1981, a
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chromatographic analysis was done to identify the major sterols and fatty acids in C.
reinhardtii (Gealt et al., 1981), in 1982, sterol synthesis was studied during the cell cyle
by Janero et al., and finally in 1999, Salimova et al., identified three sterol mutants that
were deficient in C24(28)reductase (Salimova et al., 1999, Janero et al., 1982). This
paper also identified a possible pathway for the synthesis of ergosterol and 7dehydroporiferasterol based on enzyme function as seen in Figure 3.1 (Bard et al., 1978,
Salimova et al., 1999). However, this pathway does not show potential substrates and
precursors for earlier biosynthetic steps of the ergosterol pathway (Bard et al., 1978,
Salimova et al., 1999). Unfortunately, from that point on very little research has been
published in this field. During these earlier years, studying specific genes of the pathway
was difficult because the BLAST tool was not yet available with the present day
conveniences of reduced cost, algorithmic efficacy, and time efficiency, and as well as
the Chlamydomonas genome was not yet sequenced. With the Chlamydomonas genome
now 95% sequenced (Merchant et al., 2007), the ergosterol biosynthetic pathway can be
predicted, and experiments designed to characterize the functions of these genes. Using
BLAST alignment tools and bioinformatics technology, determinations of possible genes
involved in ergosterol biosynthesis in C. reinhardtii can be made. Elucidation of the
ergosterol pathway in C. reinhardtii will provide more insight into the significance of this
lipid molecule and provide the groundwork for possible manipulation of these enzymes
for further analysis and study.
3.2 Results
C. reinhardtii has been described as having two major sterols in its membrane,
ergosterol and 7-dehydroporiferasterol (Gealt et al., 1981). By making use of BLAST
sequence alignment tools on the NCBI database, several enzymes in the yeast pathway
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Figure 3.1 The Ergosterol Pathway in C.reinhardtii. This diagram shows the reactants,
enzymes and precursors to ergosterol and 7-dehydroporiferasterol in C.reinhardtii as
described in (Bard et al., 1978, Salimova et al., 1999). Gene names have been added to
the original pathway as well as the gene responsible for the alkylation of the second
branch of the pathway that produces 7- dehydroporiferasterol.
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for ergosterol biosynthesis were analyzed for sequence similarity in C. reinhardtii.
Information about the structure and function of these enzymes was used to identify
possible genes of interest involved in ergosterol biosynthesis in C. reinhardtii.
Sequences of ergosterol biosynthetic enzymes were gathered from the
Saccharomyces Genome Database (www.yeastgenome.org). These sequences were then
aligned against the JGI Chlamydomonas Genome Version 4.0 database
(http://genome.jgi-psf.org/Chlre4/Chlre4.home.html) using the BLAST algorithm to
identify sequences with similarity and identity. For each enzyme two or three genes
showed significant homology. Only those sequences with the best E-value were chosen
as potential candidates for each of the genes (Table 3.1). An E-value is a statistical
number denoting a high sequence similarity between a query and subject sequence.
Some of the genes of the ergosterol biosynthetic pathway were then named and annotated
by Dr. J.V. Moroney as part of his contribution to the Chlamydomonas JGI Annotation
Team (Merchant et al., 2007). In addition, we also determined the exon number, length
of genomic and cDNA, as well as putative protein function (Table 3.2) (Merchant et al.,
2007), so as to better design a proposed pathway for ergosterol biosynthesis in C.
reinhardtii (Figure 3.2). Each gene is described based on previous research discoveries
in S. cerevisiae. Hopefully, this information will give scientists some groundwork to
design more efficient experiments to begin characterization of these genes.
3.2.1 ERG20
Using the S. cerevisiae amino acid sequence to search the Chlamydomonas
genome database, one gene was identified with an E-value of e-102 (Table 3.1). Located
on Chromosome 3, ERG20 was identified as a farnesyl diphosphate synthetase (Table
3.2) based on its function yeast. The proposed reaction catalyzed by Erg20p is explained
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Table 3.1. Chlamydomonas Ergosterol Genes and Genome Location.
Chlamydomonas Ergosterol Gene
ERG20 (FPPS)
ERG9
ERG1
ERG7 (CAS1)
ERG6 (SMT1)
CP1*
ERG11 (CYP51G1)
CDI1*
ERG25
ERG26
ERG28
ERG3
ERG5 (CYP710B1)
ERG4/24

E-value
e-102
2e-75
5e-69
e-103
9e-63
2e-86
5e-59
6e-38
7e-13
3e-39
4e-08
8e-25
2e-52
3e-36

Genome Location
Chromosome 3:
Chromosome 3:
Chromosome 15:
Chromosome 1:
Chromosome 12:
Chromosome 16:
Chromosome 2:
Chromosome 12:
Chromosome 6:
Chromosome 10:
Chromosome 13:
Chromosome 16:
Chromosome 18:
Chromosome 2:

7017328-7021524
3398442-3402247
2524204-2531216
1873239-1882768
2020653-2024227
1259701-1263345
2409617-2414200
8843417-8845452
1665867-1669592
3130700-3133000
878655-881039
2115065-2117963
1235761-1240121
482034-486648

*Derived from pBLAST alignment of CP1 and HYDRA1 from Arabidopsis thaliana.
Higher plant nomenclature denoted in parentheses.

Table 3.2. Chlamydomonas Ergosterol Gene Information and Protein Function.

*Derived from pBLAST alignment of CP1 and HYDRA1 from Arabidopsis thaliana.
Higher plant nomenclature denoted in parentheses.
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Figure 3.2. Proposed Pathway for Ergosterol Biosynthesis in C.reinhardtii. Sterol
pathway showing the reactants and enzymes that catalyze the steps to synthesize
ergosterol in C. reinhardtii. Based on EST data from JGI VERSION 4.0,
Chlamydomonas lacks similar sequences for ERG27 and ERG2 from S. cerevisiae, but it
does show sequence homology with CPI1 and CDI1, genes involved in sterol
biosynthesis in Arabidopisis thaliana. This working model may change as these genes
are characterized.
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in Figure 3.3. The length of the genomic DNA and cDNA are approximately 1.7 kb and
1.1 kb, respectively. ERG20 has 12 exons (Figure 3. 4B) and a coding sequence of 1083
nucleotides (Figure 3.4A) which encodes a 360 amino acid polypeptide (Figure 3.4C).
ERG20 encoded a protein that also showed homology with the farnesyl disphosphate
synthetase of A. thaliana (Accession No. CAA53433), as well (Figure 3.5). ERG20 has
been characterized by functional complementation in yeast (Delourme et al., 1994). C.
reinhardtii Erg20p has 52% sequence identity to farnesyl diphosphate synthetase from A.
thaliana and 49% identity to Erg20p in S. cerevisiae. The Arabidopsis gene for this
important enzyme in isoprenoid and sterol biosynthesis, ERG20, is found on
Chromosome 3 in C. reinhardtii and has 12 exons. The gene model is completely
supported by EST data. The predicted 360 amino acid protein is soluble and lacks
transmembrane helices.
In yeast, the ERG20 homolog, is described as an essential gene that feeds C10
precursors to several lipid pathways including sterol biosynthesis (Anderson et al., 1989).
The enzyme functions to couple IPP to dimethylallyl diphosphate and geranylphosphate
to produce C15 metabolites that can enter the sterol biosynthetic pathway (Anderson et
al., 1989). Two yeast ERG20 mutants were identified and as a result produce geraniol
and farnesol which are toxic alcohols (Chambon et al., 1990).
3.2.2 ERG9
Erg9p in C. reinhardtii is described as a farnesyl-diphosphate farnesyl transferase.
The primary function of the protein is to join two farnesyl pyrophosphates to form
squalene (Figure 3.3). This biosynthetic branch point is thought to regulate the flow of
isoprene units into the sterol pathway (Jennings et al., 1991). Erg9p in yeast contains a
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Figure 3.3. Schematic diagram of the elongation of squalene. Isoprene units are joined
together by Erg20p and Erg9p to form squalene.
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Figure 3.4. Full Length cDNA Sequence and Gene Structure of ERG20 and Amino
Acid Sequence of Erg20p. A: Full length cDNA sequence of the C. reinhardtii ERG20
gene. Start and Stop codons are shown in the green boxes, respectively. B: Gene
structure of the C. reinhardtii ERG20 gene. Start and Stop codons are denoted by the
black vertical bars. C: Amino acid sequence of the Erg20 protein.
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Figure 3.5. Multiple Alignment of ERG20. Multiple sequence alignment of C.
reinhardtii Erg20 protein with homologs from A. thaliana and S. cerevisiae. The
“*”denotes identical amino acid residues. The “:” denotes conserved residues. The “.”
denotes residues that are semi-conserved.
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PEST consensus motif that is thought to be a potential site for phosphorylation of
serine/threonine residues for the purpose of ubiquitination (Rogers et al., 1986). Erg9p
lacks the PEST consensus motif in C. rienhardtii, but it does show sequence similarity
with another portion of the yeast Erg9 protein. This particular sequence,
MMGLFLQKTNIIRDYNEDLVDGRS, is a putative prenyl substrate motif (Jennings et
al., 1991) (Figure 3.6). ERG9 is predicted to encode a soluble 378 amino acid protein
and the gene structure, located on Chromosome 3, and has 10 exons and 9 introns.
While, the genome produces a strong match for this gene with an E-value of 2e-75, the
EST data in support of this gene model are very weak.

Figure 3.6. Full Amino Acid Sequence of Erg9p. The amino acid sequence of Erg9
protein. The putative prenyl substrate motif is highlighted in the red box.
3.2.3 ERG1
ERG1 is highly conserved among eukaryotic organisms producing sterols. In
Saccharomyces cerevisiae, Erg1p is classified as a squalene epoxidase and is responsible
for catalyzing a major reaction in the ergosterol biosynthetic pathway (Jandrositz et al.,
1991). The essential role of Erg1p is to facilitate the reaction responsible for introducing
a molecular oxygen at the 2,3 position of squalene to produce squalene epoxide (Ryder,
1990) (Figure 3.7). By eliminating ERG1 in yeast, auxotrophic mutants are created.
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Without an ergosterol supplement in the media, under anaerobic conditions these
mutations are lethal (M'Baya et al., 1989). ERG1 is also a target for the antifungal class
of drugs called terbinafines (Ryder, 1991, M'Baya et al., 1989).
Like yeast and Arabidopsis, Chlamydomonas reinhardtii possesses a similar
protein called Erg1p. It is also characterized in the JGI Chlamy Version 4.0 Database as
having oxidoreductase activity. The protein is predicted to have two transmembrane
helices. Protein family alignment (Pfam) of the protein sequence for C. reinhardtii
reveals a domain structure with similarities to a FAD dependent oxidoreductase. Found
on Chromosome 15, ERG1 has 12 exons. Its genomic DNA is about 2.1 kilobases while
its cDNA is 1.6 kilobases. The gene model for ERG1 has partial EST support, there is a
portion of the gene where there is no EST data. It must be noted that the ERG1 gene is
not annotated in the JGI Chlamy Version 4.0 Database.
3.2.4 ERG7- Cycloartenol Synthase
Cycloartenol synthase catalyzes the reaction from 2,3 epoxysqualene to
cycloartenol. This critical step is a major evolutionary branch point between
photosynthetic eukaryotes and nonphotosynthetic organisms like yeast (Benveniste,
2004) (Figure 3.7 ). For example, in S. cerevisiae 2,3-epoxysqualene is cyclized to
lanosterol (Benveniste, 1986) by a 2,3- OS lanosterol cyclase or Erg7p. Functional
complementation of yeast mutants lacking lanosterol synthase with A. thaliana
cycloartenol synthases led to the discovery of CAS1 (Corey et al., 1993). Very
interestingly, A. thaliana cycloartenol synthase has been shown to produce lanosterol
when point mutations are present (Y410T or H477N) (Benveniste, 2004, Segura et al.,
2002, Herrera et al., 1998, Hart et al., 1999).
Lanosterol synthase and cycloartenol synthase are quite similar with more than
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Figure 3.7. Schematic diagram showing the biochemical reactions from squalene to
cycloartenol and lanosterol. ERG1 catalyzes the conversion of squalene to squalene
epoxide. This step is highly conserved among eukaryotic organisms. The branch between
nonphotosynthetic eukaryotes and photosynthetic organisms shows the differentiation in
structure among higher plants, algae, fungi and mammals. ERG7 and CAS1 catalyze
these reactions.

41

35% identity between the genes. Summons et al. has identified key amino acid
differences between lanosterol synthase and cycloartenol synthase (Summons et al.,
2006). Amino acids at position T/Y381, C/Q/H449, and V/I453 are conserved among
lanosterol and cycloartenol synthase, while amino acid D455 is thought to be a highly
conserved catalytic residue (Summons et al., 2006). Looking at these specific amino
acids, C. reinhardtii sequence aligns well with the higher plant sequence for cycloartenol
synthase (Figure 3.8). The identification of CAS1 supports the idea that C. reinhardtii
does follow a sterol biosynthetic pathway very similar to that of higher plants. The gene
is found on Chromosome 1. It has 20 exons (Figure 3.9) and sequence alignment reveals
a 34% similarity between lanosterol synthase, Erg7p, in yeast and 58% sequence
similarity with cycloartenol synthase in A. thaliana (Figure 3.10). While CAS1 has been
annotated, there is very little EST data to support this model.
3.2.5 ERG6- Sterol-C- Methyltransferase
Ergosterol biosynthesis is thought to be highly conserved across several different
species, including humans, but the biosynthetic step that ERG6 catalyzes is not found in
Homo sapiens (Jensen-Pergakes et al., 1998). Erg6p in yeast is a ∆(24)-sterol Cmethyltransferase (Gaber et al., 1989). It is thought to catalyze the conversion of
zymosterol to fecosterol by methylating position C-24 in yeast. In higher plants, like A.
thaliana, ERG6 is called SMT1 and catalyzes two steps. It is responsible for both the
conversion of cycloartenol to 24- methylene cycloartenol (Wojciechoswki et al., 1973),
as well as catalysis of 24-methylenophonol to 24- ethylenophenol (Fonteneau et al.,
1977). ERG6 is responsible for these two separate steps in sterol biosynthesis in higher
plants as well as C. reinhardtii. The primary difference between vertebrate sterols and
those of fungi and higher plants is an extra alkyl group on carbon 24 (Nes, 2000).
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Figure 3.8. Multiple Alignment of Lanosterol and Cycloartenol Synthase Across
Species. The colored amino acids are denoted as being diagnostic between LAS and
CAS. At position 381 threnonine is conserved in LAS but tyrosine is conserved in CAS.
Likewise in position 449 is a C or Q in LAS and and H in CAS. Poision 453 is a V in
CAS and an I in LAS. While posistion 455 is conserved among both as the catalytic
amino acid The crystal structure of the oxidosqualene cyclase in H. sapiens has been
published (Thoma et al., 2004).

Figure 3.9. Exon- Intron Structure of CAS1 in C. reinhardtii.
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Figure 3.10. Multiple Alignment of Erg7p and Cas1p. Multiple sequence alignment of
C. reinhardtii cycloartenol synthase protein with homologs from A. thaliana and S.
cerevisiae. The “*”denotes identical amino acid residues. The “:” denotes conserved
residues. The “.” denotes residues that are semi-conserved.
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Erg6p or sterol- C- methyltransferase is responsible for the catalysis of this side chain.
Preliminary information about the gene in C.reinhardtii reveals that SMT1 is
located on Chromosome 12. In C. reinhardtii, Smt1p is a soluble protein and is a
member of the SAM dependent methyltransferase protein family
(http://pfam.sanger.ac.uk). SAM dependent methyltransferases are responsible for the
transfer of methyl groups to other biological molecules for sterol biosynthesis and even
DNA repair (http://pfam.sanger.ac.uk). SMT1 in C. reinhardtii has a cDNA sequence of
1.2 kilobases, and its intron-exon structure spans the genome at 1.8 kilobases.
Bioinformatics evidence reveals only one copy of SMT1 in Chlamydomonas in contrast to
the three found in Arabidopsis. There is strong EST support for this gene. The EST data
also indicated that two forms of the Smt1 protein may exist in Chlamydomonas as there
appears to be alternative splicing with one form of the gene.
3.2.6 ERG25, ERG26, ERG28 – Sterol C-4 Demethylation Complex
The C-4 demethylation complex includes proteins Erg25p, Erg26p, and Erg27p in
yeast (Mo et al., 2004). The end product sterols are converted from cycloartenol by way
of the removal of two methyl groups at position 4 and 14 (Benveniste, 2004a). It has
been established that three enzymes are used to convert 24-methylene cycloartenol to
cycloeucalenol in maize embryos (Pascal et al., 1993). The first enzyme Erg25p serves
as a C-4 methyl oxidase (Bard et al., 1996). Erg26p is a C4- decarboxylase/ C3dehydrogenase, and finally Erg27p completes the demethylation by its 3-keto reductase
activity (Pascal et al., 1994). These enzymes also catalyze the conversion of 24methylene or 24-ethylidene lophenol to episterol and avenosterol respectively in A.
thaliana (Benveniste, 2004a).
It must be noted however that A. thaliana does not show any homologous protein
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matches for Erg27p. Blastp search of the JGI genome database also reveals that C.
reinhardtii also lacks an ERG27 gene. ERG25 in Chlamydomonas is found on
Chromosome 6 and has 6 exons. It is predicted to have 4 transmembrane domains.
ERG26 is identified as a 2.3kb gene on Chromosome 12. While these genes have not
been characterized in C. reinhardtii, Smop (sterol-4α-methyl oxidase or Erg25p) from
Arabidopsis was identified by functional complementation in yeast ERG25 mutants
(Darnet et al., 2001).
From an evolutionary perspective, it is still largely unknown how or why this
methylation is possible without the 3-keto reductase activity of Erg27p. In 2003, Mo et
al. showed that ERG27 was essential and required for ERG7 activity in yeast (Mo et al.,
2003). Although Erg27p has not been identified in A. thaliana or C. reinhardtii, SMO
genes offer new information about other possible enzymes that may be performing ketoreductase activity in higher plants. When SMO1 and SMO2 gene expression is reduced in
Nicotiana benthamina, 24-methylene cycloartenol and 24-methylene and 24- ethylidene
lophenol accumulate as precursors (Schaller, 2004). However, there is an additional
protein identified in yeast that is thought to stabilize and anchor the sterol C-4
demethylation enzyme complex to the ER (Mo et al., 2004) (Figure 3.11). This protein is
called Erg28p and is conserved in A. thaliana as well as C. reinhardtii (Gachotte et al.,
2001). Erg28p is found on Chromosome 13 and has 5 exons. While this gene is not
annotated and is poorly characterized in the JGI Genome Version 4.0, an NCBI blast of
non-redundant protein sequences does reveal a match to the ERG28 superfamily.
In the current model (Mo et al., 2004), Erg28p is thought to bridge between the
demethylation complex (Erg25p, Erg26p, Erg27p) and the other sterol biosynthetic
proteins such as Erg3p and Erg6p (Figure 3.11A). Another enzyme found in close
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proximity to the Erg28p bridge is Erg2p. There were no sequences identified by a blastp
search of yeast ERG2 to Chlamydomonas (Figure 3.11B). Comparision of the yeast
pathway to that of the Arabidopsis pathway reveals that this gene may not be necessary in
order to achieve the demethylation steps and the production of the final end steps of
ergosterol biosynthesis in C. reinhardtii (Figure 3.11C). There was sufficient EST
support for ERG25, ERG26 and ERG28. However, because ERG27 was not confirmed
after the BLASTp search, there was no EST support for this gene.
3.2.7 CPI1- Cyclopropyl Sterol Isomerase
CPI1 was a very important gene to identify by bioinformatics analysis. This gene
is found primarily in the plant kingdom and denotes use of the cycloartenol pathway
versus the lanosterol pathway. Cyclopropyl sterol isomerase functions to open a
cyclopropane ring in cylcoeucalenol to catalyze the production of obtusifoliol (Rahier et
al., 1989, Heintz & Benveniste, 1974) (Figure 3.12). This gene is primarily restricted to
the plant kingdom. Many studies have looked at agricultural pesticide targeting to CPI1
in higher plants (Benveniste, 1986), but this gene has not been analyzed in C. reinhardtii.
With the exception of the bioinformatics data presented here, scientists have yet to
investigate the role of this gene in the model system. It has been found that CPI1 is a
drug target for two parasitic amoebae, Acanthamoeba and Naegleria (Raederstorff &
Rohmer, 1985, Raederstorff & Rohmer, 1987). Humans and other vertebrate organisms
do not have this gene and therefore are unlikely to be affected by drugs specifically
targeting CPI1.
CPI1 is located on Chromosome 16. The genomic DNA spans 1.9 kb and the
cDNA is 0.8 kb in size (Figure 3.13A). CPI1 gene has 8 exons, (Figure 3.13B), and the
protein is 276 amino acids long (Figure 3.13C). While very little is known about the
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Figure 3.11. Schematic diagram of the Sterol C-4 Demethylation Complex. (A)
Erg28p anchors the complex in yeast and forms a bridge between Erg27p and Erg6p in
this protein- protein interaction. Modified from (Mo et al., 2004). (B) Erg27p and Erg2p
are absent in the genomes of both Chlamydomonas and Arabidopsis. (C) A proposed
schematic diagram of Erg28p bridging Erg26p to Erg6p.
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gene in C. reinhardtii, the presence of strong EST support for CPI1 does give sufficient
data and support for the idea of a more plant-like pathway from squalene to episterol.
3.2.8 ERG11- Lanosterol 14α-Demethylase /CYP51G1- Obtusifoliol 14αDemethylase
ERG11 and CYP51G1 are responsible for two different conversions in higher
plants and fungi. Lanosterol is the substrate of Erg11p in yeast; in contrast, obtusifoliol is
the substrate in higher plants (Delye et al., 1998, Taton & Rahier, 1991). Even though
these two enzymes utilize different substrates, they both have the conserved protein
sequence FGxGRHxCIG that represents a Cytochrome p450 cysteine-heme iron ligand
binding signature (Figure 3.14). While Cytochrome p450 proteins are highly substrate
specific, heterologous complementation from yeast to higher plant is often very difficult.
Even though a higher plant to yeast ERG11 complementation has been reported, the
authors had to optimize the REDOX environment by overexpressing an additional
cytochrome p450 protein in order to assist in the direct complementation of the higher
plant ERG11 in yeast (Cabello-Hurtado et al., 1999).
BLASTP alignment with the yeast Erg11 protein sequence to the Chlamydomonas
genome revealed that CYP51G1 is found on Chromosome 2 and is predicted to encode a
sterol 14- desaturase. With 10 exons, the gene spans 2.7 kb and its cDNA is 1.5 kb long.
The EST support for CYP51G1 is very strong. The sequence of Cyp51G1p is 52%
similar to the sequence of Cyp51G1 for Arabidopsis, while, it is only 28% similar to
Erg11p in yeast. But, all three sequences have the Cytochrome p450 cysteine-heme iron
ligand binding signature (Figure 3.14).
3.2.9 ERG4/24- C-24(28) Reductase/C-14 Sterol Reductase
ERG4 and ERG24 are two separate genes in S. cerevisiae. Erg4 protein in C.
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Figure 3.12. Schematic diagram of the chemical conversion of cycloeucalenol to
obtusifoliol. CPI1 helps open the cyclopropane ring of cycloeucalenol to form
obtusifoliol.
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Figure 3.13. Full Length cDNA Sequence and Gene Structure of CPI1 and Amino
Acid Sequence of Cpi1p. A: Full length cDNA sequence of the C. reinhardtii CPI1
gene. Start and Stop codons are shown in the green boxes, respectively. B: Gene
structure of the C. reinhardtii CPI1 gene. Start and Stop codons are denoted by the
black vertical bars. C: Amino acid sequence of the Cpi1 protein.
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reinhardtii is 26% similar to Erg24p in yeast, and Erg4p is found on Chromosome 7
while ERG24 is found on Chromosome 14. Each have their own function, but BLASTP
search of the Chlamydomonas genome reveals only one gene for both ERG4 and ERG24.
In C. reinhardtii, ERG4/24 is located on Chromosome 2. The protein is predicted to have
8 transmembrane helices, while, the gene has 7 exons and 6 introns. C. reinhardtii
Erg4/24p is 30% similar to yeast Erg4p and 37% similar to yeast Erg24p (Figure 3.15).
The dual functions of Erg4/24p are sterol C-24(28) reductase and C-14 sterol reductase
activity. The EST support is very strong for this gene. ERG4/24 in C. reinhardtii
belongs to the ergosterol biosynthesis ERG4/24 family according to Pfam predictions and
NCBI Blast predictions. The major function of this protein is to reduce double bonds in
the precursors of ergosterol (Lai et al., 1994).
While BLASTp searches with Erg4p and Erg24p from S. cerevisiae reveals only
one gene corresponding to both in C. reinhardtii, A. thaliana does possess a C-14 sterol
reductase. The gene known as FACKEL (At3g52940) encodes a C-14 sterol reductase
that catalyzes the C-14 demethylation of obtusifoliol (Benveniste, 2004b). Fackelp has
been characterized, and the fk mutation in A. thaliana promotes the accumulation of Δ8,14
sterol intermediates (Klahre et al., 1998). A. thaliana also has a Δ24, 28 sterol reductase,
Dwf1p. DWF1 performs several steps in the A. thaliana sterol pathway, but its primary
role is the isomerization and reduction of bonds located at C- 24,28 (Klahre et al., 1998).
Unfortunately, at this time there is no purified protein of DWF1.
3.2.10 CDI1- Δ8-Δ7 Sterol Isomerase
During sterol biosynthesis, the methyl group of Carbon 14 is removed in higher
plants, algae and fungal species. Following this step, Δ7 sterols are produced by a Δ8-Δ7
isomerase (Benveniste, 2004). Erg2p is the equivalent Δ8-Δ7 isomerase, however, upon a
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Figure 3.14. Sequence similarity between ERG11 protein sequences in
Chlamydomonas reinhardtii, Arabidopsis thaliana, and Saccharomyces cerevisiae .
Identical protein sequences are denoted by an asterisk. The Erg11p sequences show a
conserved protein sequence FGxGRHxCIG that is highlighted in blue. This motif
represents a Cytochrome p450 cysteine-heme iron ligand binding signature. The
“*”denotes identical amino acid residues. The “:” denotes conserved residues. The “.”
denotes residues that are semi-conserved.
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Blastp search of the Chlamydomonas genome, no sequences homologous to ERG2 are
found. When taking the same ERG2 sequence and doing a Blastp search of the
Arabidopsis genome, no equivalent matches are found. However, another gene HYDRA1
in A. thaliana has been identified to have a similar function to ERG2 in yeast despite its
low sequence similarity. HYDRA1 gene does complement the genetic phenotype of
erg2Δ mutants in S. cerevisiae (Benveniste, 2004a, Benveniste, 2004b). Blastp search of
the Chlamydomonas genome with Hydra1p does reveal one gene annotated as CDI1.
This gene has 5 exons and is located on Chromosome 12. Although these genes are
annotated as functioning as Δ8-Δ7 isomerases, it must be noted that there is no
experimental evidence in C. reinhardtii to support this claim. However, the EST support
for this gene is extremely strong. When analyzing the sequence of Erg2p in yeast,
Hydra1p in Arabidopsis, and Cdi1p in Chlamydomonas, there is very little sequence
identity among the three sequences (Figure 3.16). There is a 37% similarity between
Hydra1p and Cdi1p, while there is a 4% similarity between Cdi1p and Erg2p.
3.2.11 ERG3-C-5 Sterol Desaturase
ERG3 has been well characterized in yeast as a C-5 sterol desaturase (Osumi et
al., 1979), as it catalyzes the Δ5- bond in the B-ring of ergosterol. This enzyme is thought
to be sensitive to cyanide and needs iron as well as molecular oxygen for its function
(Skaggs et al., 1996). ERG3 in yeast is also associated with NAD(P)H-cytochrome b/
cytochrome b5 (Osumi et al., 1979). Deletion of ERG3 in Saccharomyces cerevisiae
produces haploid cells that overaccumulate the ergosterol precursor episterol.
ERG3 in C.reinhardtii is located on Chromosome 16 of the genome and functions
as a C-5 sterol desaturase. The genome database predicts that this particular protein has 3
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Figure 3.15. Sequence similarity between S. cerevisiae Erg4p and Erg24p and C.
reinhardtii Erg4/24p. The “*”denotes identical amino acid residues. The “:” denotes
conserved residues. The “.” denotes residues that are semi-conserved.
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Figure 3.16. Sequence similarity between Δ8-Δ7 isomerases in Chlamydomonas
reinhardtii, Arabidopsis thaliana and Sacchromyces cerevisiae. The “*”denotes
identical amino acid residues. The “:” denotes conserved residues. The “.” denotes
residues that are semi-conserved.
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transmembrane helices. The first helix is thought to be located at amino acids 10-32, the
second and third helix correspond to amino acids 110-132 and 191- 213. According to
Pfam analysis, Erg3 protein from C. reinhardtii belongs to the fatty acid hydroxylase
superfamily. This superfamily of proteins includes C-5 sterol desaturases as well as C-4
sterol methyl oxidases. ERG3 has 6 exons and 5 introns, and its protein sequence has
similar sequence identity with Erg3p of S. cerevisiae. The EST support for this gene is
very strong. This gene will be discussed further in Chapter 4.
3.2.12 ERG5
ERG5 is considered to be a member of the cytochrome P-450 superfamily in yeast
(Kelly et al., 1997). The primary function of this protein is the conversion of ergosta-5,7dienol to ergosta- 5,7,22,24-tetraen-3β-ol. As a C-22 sterol desaturase, Erg5p catalyzes
insertion of a double bond in the sterol side chain and is thought to be susceptible to azole
antifungal drugs (Aoyama et al., 1984). Bard et al. identified C. reinhardtii mutants
lacking ergosterol (Bard et al., 1978). These mutations are consistent with a loss of
ERG5 activity. ERG5 is found on Chromosome 18 and has 9 exons. Pfam predictions
designate Erg5p has having a p450 conserved domain between amino acids 214 and 413.
JGI reveals a molecular function of monoxgenase activity. There is partial EST support
for this gene.
3.2.13 Ergosterol Biosynthetic Gene Expression
In 1978, the first sterol mutants were identified in C. reinhardtii. These mutants
were described as being 22(23) desaturase mutants (Bard et al., 1978). ERG5 is denoted
as the C-22 desaturase gene in C. reinhardtii according to bioinformatics analysis. ERG5
catalyzes two steps in the sterol pathway of C. reinhardtii. Erg5p helps to introduce
double bonds in ergosta- 5,7,24(28)- trienol and stigmasta-5, 7, 24(28)- trienol to produce
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ergosta- 5,7,22, 24(28) –tetraenol and stigmasta- 5,7,22, 24(28)- tetraenol. Upon
investigation of one of these original sterol mutants, quantitative real time PCR (Q-RT
PCR) revealed that cc652 does lack expression of ERG5 (Figure 3.17). While, it is not
known what part of the gene the point mutation exists, the Q-RT PCR results corroborate
the original work that cc652 has a defective ERG5 gene (Bard et al., 1978).
In 1982, Janero et al., were the first to analyze cell cycle variations in sterol
biosynthesis in Chlamydomonas. Their analysis revealed that sterol biosynthesis was
highly active during the light period while there was a sharp decrease during the dark
period. They also demonstrated that there is a marked increase of sterol synthesis during
the transition from the dark to the light period by some 30 fold. With this information, it
was decided that an analysis of specific ergosterol biosynthetic genes during membrane
biogenesis of reflagellation was in order. Reflagellation is the process by which the
flagella can regenerate after manual or chemical excision such as pH shock. Analysis of
several key genes in sterol biosynthesis showed some sterol biosynthetic gene increases
in expression during reflagellation (Figure 3.18).
It was of interest that ERG11 showed the greatest relative expression after 30
minutes of reflagellation. Erg11p is responsible for the conversion of cycloeucalenol to
obtusifoliol in higher plants (Benveniste, 2004). The Erg11 enzyme is also extremely
substrate specific. ERG3, ERG4, ERG5, ERG6, and ERG7 show moderate increases in
relative expression during reflagellation compared to ERG11. These genes are
responsible for some key steps in the pathway as described earlier, but it appears as
though these genes turn on after 30 minutes of reflagellation, and then their expression
returns to levels seen before the loss of the flagella. However, unlike ERG3, ERG4,
ERG5 and ERG7, ERG6 stays active throughout the duration of the entire reflagellation
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Relative Expression

*

Figure 3.17 Q-RT comparative analyses between wild type cells and a wellcharacterized sterol mutant cc652. In the experiment, the expression of each sterol
gene wild type cells was set to 1 and the expression of the mutants was compared. The
asterisk (*) denotes the absence of ERG5 expression.
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cycle of 120 minutes. When looking at the pathway, it must be noted that ERG6 is
responsible for catalyzing several steps in the ergosterol biosynthetic pathway. This gene
may remain active to express more protein to catalyze these multiple steps in the
pathway. Finally, ERG25 and ERG26 were also analyzed to identify their levels of
expression during reflagellation, and itappears that these genes are constitutively
expressed. It must be noted that these two genes are a part of the C-4 demethylation
complex and interact in a multi-step process to remove methyl groups from carbon 4 of
the sterol nucleus. These observations led me to investigate whether C. reinhardtii
“Bald” mutants that completely lacked flagella showed any changes or absences of these
ergosterol biosynthetic genes. The data provided no conclusive information (Figure.
3.19) However, cc478 gave no expression level for ERG7. Erg7 is a critical enzyme in
ergosterol biosynthesis in higher plants and algae as it is responsible for the conversion of
squalene epoxide to cycloartenol versus lanosterol. It would be of specific interest to
study whether or not this gene has any role in cooperation with other genes of the IFT
machinery. ERG11 is also down-regulated in strain cc478.

This data may or may not

be significant, but cc478 does raise some interesting questions, due to the regulation of
these two key genes, ERG7 and ERG11 during reflagellation.
3.3 Discussion
Biochemical research has provided extensive knowledge about the lipid
composition of C. reinhardtii membranes, but little is known about the enzymatic
mechanisms by which these lipids are produced. This chapter presents a bioinformatics
analysis of the genes involved in ergosterol biosynthesis in C. reinhardtii. In a recent
review by Pierre Benveniste (Benveniste, 2004), he gives a thorough analysis and
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Relative Expression

Figure 3.18. Time course analysis of ergosterol gene expression during
reflagellation. The expression of each gene was set at 1 for the control cells. Error bars
represent standard deviation of these replicates.
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Relative Expression

Figure 3.19. Q-RT analysis showing the difference in ergosterol gene expression
between wild types cells with flagella and several bald mutants lacking flagella.
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description of each gene found in Arabidopsis thaliana and the hallmark experiments
used to analyze each specific enzyme. Comparing the material presented by Benveniste
and the two pathways for sterol biosynthesis in S. cerevisiae and A. thaliana, we gathered
information to construct a putative pathway in C. reinhardtii for further study and
experimentation.
While it has been several decades since ergosterol and 7-dehydroporiferasterol
were identified in the cell and flagella membranes in C. reinhardtii, scientists have not
identified any important links between these two sterols and other cellular processes in
the cell. However, our quantitative RT- PCR data does reveal significant ergosterol gene
regulation during reflagellation. Even though most of the reflagellation studies look
primarily at intraflagellar transport proteins, there may be other aspects of this
phenomenon of reflagellation that yet to be discovered.
As the depth of research knowledge into lipid rafts, flagellar regeneration,
photosynthesis and reproduction in this species continues to grow, the ergosterol pathway
may prove to be of major interest in the manipulation of lipid species in C. reinhardtii.
Sterol studies have proven to be extremely significant to the world of antifungal drug
production in yeast. Targeting the ergosterol biosynthetic pathway enzymes has offered a
unique approach to drug design. The genes of the sterol biosynthetic pathway are often
seen to be highly conserved across species with variations in precursors and endproducts. Bioinformatics analysis of the ergosterol biosynthetic pathway may allow for
new innovative ways to identify key enzymes that may play dual roles in the structure
and function of the cell membrane. Identification of a proposed pathway will give the
background information needed to now definitively study ergosterol biosynthesis in the
model system, C. reinhardtii.
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CHAPTER 4
IDENTIFICATION OF ERG3, A GENE INVOLVED IN THE
BIOSYNTHESIS OF ERGOSTEROL IN CHLAMYDOMONAS
REINHARDTII

4.1 Introduction
One gene essential to ergosterol biosynthesis is ERG3. ERG3 encodes the C-5
sterol desaturase responsible for introducing a double bond at C-5 in the B ring of
episterol (Osumi et al., 1979) (Figure 4.1). This enzyme is sensitive to cyanide and
requires iron as well as molecular oxygen for its activity (Arthington-Skaggs et al.,
1996). ERG3 in yeast is also associated with NAD(P)H-cytochrome b/ cytochrome b5
(Osumi et al., 1979). It has been previously demonstrated that ERG3 is required for the
breakdown of respiratory substrates when cells are heme deficient (Smith & Parks, 1993).
Deletion of ERG3 in S. cerevisiae produces haploid cells that overaccumulate the
ergosterol precursor, episterol (Miller & Rampling, 1982, Parks et al., 1982). Episterol
and ergosta-7, 22-dien- 3-beta-ol are reported as possible substrates for the C-5 sterol
desaturase (Daum et al., 1998). Cloning and sequencing of ERG3 has been reported in
several model systems including Arabidopsis thaliana (Gachotte et al., 1996) and Homo
sapiens (Miyazaki et al., 1999). In yeast, ERG3 is a non-essential gene except under
environments of heme-deficiency (Smith & Parks, 1993). It has been suggested that Erg3
protein is a critical target in ergosterol biosynthesis (Nes & Dhanuka, 1988), and when
other ergosterol biosynthetic enzymes are mutated, ERG3 expression is directly affected
and regulated by these mutations (Arthington-Skaggs et al., 1996). Chlamydomonas
reinhardtii, has elicited great interest as a model system in the field of lipid research, and
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several membrane lipids of C. reinhardtii have been identified (Janero & Barrnett, 1981b,
Janero & Barrnett, 1982a Janero & Barrnett, 1982b, , Janero & Barrnett, 1981a, Giroud et
al., 1988). Monogalactosyldiacylglycerol (MGDG), digalactosyldiacylglycerol (DGDG),
sulfoquinovosyldiacylglycerol (SQDG), diacylglyceryltrimethylhomoserine (DGTS),
phosphatidylglycerol (PG), phosphatidylethanolamine (PE) and phosphatidylinositol (PI)
are the major lipids in the membranes of Chlamydomonas, but phosphatidylcholine (PC)
and phosphatidylserine (PS) are absent (Giroud et al., 1988). Although, PC is absent in
the membranes of C. reinhardtii, our laboratory has confirmed that
ethanolaminephosphtransferase from C. reinhardtii is capable of providing for synthesis
of both PE and PC, apparently by methylation of PE in yeast via the Kennedy pathway
(Yang et al., 2004a, Yang et al., 2004b). Like yeast, Chlamydomonas reinhardtii has
been reported to have two major sterols in its plasma membrane: ergosterol and 7dehydroporiferasterol (Gealt et al., 1981). However, very little research has been done to
elucidate the specific ergosterol biosynthetic pathway in C. reinhardtii, especially with
respect to its functions and biosynthetic precursors. In this study, we begin to
characterize the function of ERG3 in C. reinhardtii by complementation in S. cerevisiae
ergosterol mutants. Understanding the substrates and respective enzymes involved in this
very complex pathway may give greater insight into the specific role of ergosterol in this
algal species.
4.2 Results
4.2.1 Sequence Analysis of the ERG3 Gene
A comparison of annotated genes in the Chlamydomonas genome to the yeast
ERG3 revealed a few genes with significant homology. The gene with the highest
homology had a 21% sequence identity to the ERG3 of yeast. The gene with the next
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highest homology had a sequence identity of only 16%, and was much more similar to
the sequence of ERG25 in yeast than ERG3. The Chlamydomonas gene also had a high
similarity to ERG3 genes from higher plants. This gene was chosen for further analysis,
and was tentatively named ERG3 (Accession No. XP_001701457).
ERG3 is a C-5 sterol desaturase that adds a double bond in the ring structure of
episterol to produce ergosta- 5,7,24 (28)-trienol in the ergosterol biosynthetic pathway
(Broach et al., 1991) (Figure 4.1). ERG3 in C. reinhardtii is located on chromosome 16
of the genome (Merchant et al., 2007). The predicted amino acid sequence of ERG3
aligns well with other C-5 sterol desaturases (Table 4.1 and Figure 4.2). The ERG3 gene
in C.reinhardtii encodes a protein of 351 amino acids (Merchant et al., 2007). The cDNA
is approximately 1.1 kb long and has six exons according to the JGI Chlamy Version 4.0
Genome (Merchant et al., 2007) (Figure 4.3). Like other known Erg3 proteins, the
homologous gene in C. reinhardtii codes for four putative histidine metal binding
domains (Miyazaki et al., 1999) (Figure 4.2). A genome database
(http://genomeportal.jgi-psf.org/Chlre4/Chlre4.home.html) predicts that Erg3 protein has
3 transmembrane helices. The first helix is thought to be made up of amino acids 10-32,
while the second and third helices correspond to amino acids 110-132 and 191- 213
(Merchant et al., 2007, Marchler-Bauer et al., 2007), respectively (Figure 4.2).
4.2.2 Deletion of ERG3 by Homologous Recombination
While ERG3 from Chlamydomonas aligned well with putative plant ERG3 genes
(Figure 4.1), its alignment with the characterized ERG3 protein of yeast showed a lesser
degree of identity and similarity. To provide evidence that Chlamydomonas ERG3
functions as a C-5 desaturase, we designed experiments to complement a yeast erg3Δ
mutant. To generate the null mutation in yeast, the ERG3 gene was deleted by
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Figure 4.1 Schematic diagram of the reaction catalyzed by ERG3 in yeast. ERG3 is
responsible for introducing a double bond at the C-5 carbon (denoted by the asterisk) of
the B-ring of episterol to produce ergosta- 5,7,24(28)- trienol. This step is the second to
last step in the biosynthetic pathway to ergosterol.
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Table 4.1. Alignment scores among sterol C-5 desaturases of various organisms
generated from ClustalW.
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Figure 4.2. Amino acid sequence alignment of Sterol C-5 desaturase in different
organisms. Arabidopsis thaliana (AtERG3) NCBI Accession Number CAA62079; Zea
mays (ZmERG3) ACG38774; Chlamydomonas reinhardtii (CrERG3) XP_001701457;
Homo sapiens (HsERG3) BAA33729; Rattus norvegicus (RnERG3) NP_446094;
Sacchromyces cerevisiae (ScERG3) NP_013157. Conserved amino acid sequences
shared by all organisms are denoted by an asterisk. The highlighted area corresponds to
the putative histidine-containing metal binding domain. Dashed lines indicate gaps in the
alignment. The bold, italicized font corresponds to the three putative transmembrane
spanning regions of the Chlamydomonas ERG3 protein.
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Figure 4.3. Schematic diagram of sterol C-5 desaturase in C. reinhardtii as
annotated in the JGI Chlamydomonas Genome Version 4.0. ERG3 has six exons and
five introns.

homologous recombination and replaced with the URA3 marker in a diploid yeast strain
(Figure 4.4A). PCR analysis was used to identify positive yeast recombinants that
possessed the ERG3 mutation, and these isolates were sporulated to obtain haploid erg3∆
strains (Figure 4.4B). Yeasts lacking a functional ERG3 are viable, as the gene is nonessential under aerobic conditions (Arthington et al., 1991). In addition, yeast lacking
ERG3 have an increased sensitivity to cycloheximide as previously described (Dudley et
al., 2005). Haploid isolates obtained from yeast ERG3 knockouts demonstrated increased
sensitivity to cycloheximide when grown under optimal conditions in rich media.
4.2.3 Complementation of ERG3 Mutants
To test the function of the C. reinhardtii ERG3 gene, complementation
experiments were conducted using yeast haploid strains deficient in ERG3. Yeast erg3Δ
strains display a marked hypersensitivity to low non-lethal levels of cycloheximide
(Dudley et al., 2005). In these experiments, plasmids expressing the yeast ERG3 ORF,
Chlamydomonas ERG3 ORF and the empty vector were transformed into the knockout
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Figure 4.4. Construction of a yeast erg3Δ strain. (A) Schematic diagram of
homologous recombination strategy used to delete ERG3 in Sacchromyces cerevisiae.
PCR primers were designed to amplify the URA3 marker gene containing the flanking
regions of ERG3. (B) Ura+ isolates were screened by PCR to verify proper integration of
URA3 and deletion of ERG3. Only correctly integrated isolates would show a 459 base
pair product using primers internal to URA3 and upstream of the flanking homology.
PCR was also used to verify the downstream end of flanking region homology with
URA3 (data not shown).

71

strains (Figure 4.5A and Table 4.2). The selectable marker LEU2 was used to select for
transformants on minimal media lacking leucine (Figure 4.5A), and Leu+ isolates were
then screened for resistance to low levels of cycloheximide (Figure 4.5B). Transformants
containing plasmid pDD1192 expressing the yeast ERG3 ORF displayed normal
resistance to low levels of cycloheximide (Figure 4.5B). Transforming the mutants with
pDD1191, expressing the Chlamydomonas ERG3 ORF, also showed enhanced resistance
to the drug (Figure 4.5B). Mutant strains transformed with the pDD1193, empty vector,
displayed very little growth on plates containing cycloheximide (Figure 4.5B). Previous
work had also reported that yeast ERG3 mutants are viable but cannot grow on nonfermentable carbon sources (Arthington et al., 1991, Smith & Parks, 1993, Hemmi et al.,
1995). We used this phenotype as a second test of the ability of the Chlamydomonas
ERG3 to complement yeast erg3Δ strains. Consistent with the earlier observations,
transformants expressing Chlamydomonas or yeast ERG3 ORFs are able to grow on
acetate as a sole carbon source, while the mutants transformed with the empty vector
control cannot grow (Figure 4.5C). All strains (Table 4.3) showed positive growth on the
control plates with minimal media minus leucine (Figure 4.5D).
To further characterize the degree of complementation, qualitative GC/ MS
analysis was performed to verify the presence of ergosterol in the complemented
transformants. Cultures of erg3Δ yeast expressing S. cerevisiae ERG3 or C. reinhardtii
ERG3 were grown to similar cell densities, collected, and lipids were extracted and
derivatized for analyses. Selected ion monitoring for ion 363 of ergosterol was used to
search the total ion chromatograph for ergosterol in the samples (Figure 4.6). When
analyzing the total ion chromatograph data for specific ions of ergosterol, the knockout
strain with the vector control was found to have a marked reduction in ergosterol in the
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Figure 4.5. Phenotypic complementation of yeast erg3Δ strains. Known phenotypes
of yeast erg3 null mutants (hypersensitivity to cycloheximide and inability to grow on
acetate) were complemented by plasmids expressing either S. cerevisiae ERG3 or C.
reinhardtii ERG3 cDNA. A) S. cerevisiae ADH1 promoter plasmid used to express ERG3
genes. Haploid yeast carrying the erg3Δ::URA3 allele were transformed with the
designated plasmids and plated on dextrose minimal media lacking leucine (YMD minus
Leu) to select for transformants. Single colony isolates were then re-streaked on minimal
media lacking leucine and containing cycloheximide (0.13 µg/mL) (B) minimal media
lacking leucine and containing acetate as sole carbon and energy sources (C), and on
YMD lacking as overall growth control (D). Yeast mutant for ERG3 and containing the
vector plasmid lacking an insert cannot grow on cycloheximide or acetate, while cells
containing the plasmid expressing either yeast or Chlamydomonas ERG3 are able to
grow. Each pair of plates represents erg3Δ yeast sporulated from two independently
isolated diploid knockout isolates, 1+2 are DDY4259 and DDY4260 transformed with
the vector only, 3+4 are DDY4261 and DDY4262, the same strains transformed with
ADH1-yeast ERG3, and 5+6 are DDY4263 and DDY4264 with ADH1-Chlamydomonas
ERG3. For the second panel, 7+8 are DDY4253 and DDY4254 transformed with the
vector only, 9+10 are DDY4255 and DDY4256 transformed with ADH1-yeast ERG3,
and 11+12 are DDY4257 and DDY4258 with ADH1-Chlamydomonas ERG3.
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Table 4.2. Plasmids used in this study.

Table 4.3. Strains used in this study.
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membranes compared to the complemented strains with the ERG3 ORF from C.
reinhardtii and S. cerevisiae (Figure 4.6). Gas chromatography data contained peaks
with retention times for the ergosterol standard, DDY 4263, and DDY 4261 respectively
at 11.46, 11.46, and 11.47 minutes.The mass ions coinciding with these specific retention
times gives spectral data with ions 468, 363, 337, and 253 m/z, previously described as
ergosterol mass ions by Griffiths et al. (Griffiths et al., 2003). These experiments
demonstrate that ERG3 from C. reinhardtii can restore ergosterol biosynthesis in yeast.
4.3 Discussion
Ergosterol is the major sterol found in membranes of C. reinhardtii. However,
sterol biosynthesis is not well understood in this organism. Several sterol mutant strains
previously were identified in C. reinhardtii by selecting for resistance to the polyene
antibiotic, nystatin (Bard et al., 1978, Salimova et al., 1999). Polyene antibiotics function
by forming complexes with the sterols in the membrane and decreasing the membrane
selective permeability, and thereby causing cell death (Lampen, 1966). In the past, this
method of selection was used to identify ergosterol mutants. However, very little is still
known about the substrate-enzyme specificity of the ergosterol biosynthetic pathway
enzymes in C. reinhardtii. Unlike C. reinhardtii, several ergosterol mutants have been
identified in yeast, and their phenotypes have been well documented (Osumi et al., 1978).
Yeast genetics allows not only the study of the function of yeast genes, but is also useful
for cross-species complementation studies.
ERG3 encodes a sterol C-5 desaturase, and belongs to the fatty acid hydroxylase
superfamily. This superfamily of proteins includes C-5 sterol desaturases as well as C-4
sterol methyl oxidases (Marchler-Bauer et al., 2007, Marchler-Bauer et al., 2005,
Marchler-Bauer & Bryant, 2004). This family of proteins possesses four putative iron75

binding domains (Miyazaki et al., 1999). Loss of ERG3 function leads to an apparent
loss of ergosterol in the membrane and an increase in the closely related precursor,
episterol. The replacement of ergosterol with episterol in yeast leads to increased
sensitivity to cycloheximide and an inability to grow with acetate as a sole carbon source
(Smith & Parks, 1993). The efficient gene replacement techniques used in Sacchromyces
cerevisiae, has allowed for the creation of mutant strains in which the ERG3 gene has
been replaced with URA3 (Rothstein, 1983, Wach et al., 1994). In the work described
here we were able to complement S. cerevisiae ERG3 haploid knockouts with both yeast
and the C. reinhardtii ERG3 ORFs. When these genes are put back into erg3Δ yeast
strains, the resultant transformants show an increase of ergosterol in the membranes,
increased resistance to cycloheximide and a restored ability to grow on the nonfermentable carbon source acetate.
While the Chlamydomonas ERG3 ORF does complement the mutation, it must be
noted that it does not complement as completely as the yeast ERG3 gene. There are
several explanations for this. Traditionally, 2 micron plasmids have been used in yeast
for heterologous complementation, in order to increase the copy number of the plasmid
and circumvent any issues regarding variations in protein stability, codon usage, and
enzyme activity across species (Ludwig et al., 1993). This study uses a moderate copy
number plasmid. Secondly, yeast and Chlamydomonas undergo two very different
biochemical pathways for the production of sterols. Yeast use the traditional MVA (IPP)
pathway for the synthesis of sterols, while Chlamydomonas utilizes the DOXP pathway
for the synthesis of sterols (Lichtenthaler, 1999). Evolutionary differences across species
allow for several variations in the ergosterol biosynthetic pathway. For example,
Chlamydomonas and S. cerevisiae produce precursors to ergosterol by two independent
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Figure 4.6. GC/MS data. Total ion chromatographs were analyzed to look specifically
for the 100% ion of ergosterol. Mass ion 363 gives the best indication of the presence or
absence of ergosterol in the samples. (A) Ergosterol standard, (B) Lipid extract from
DDY4259 vector control, (C) DDY4263 expressing C.reinhardtii ERG3, (D) DDY4261
expressing S. cerevisiae ERG3.
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pathways so therefore similar enzymes can often catalyze different reactions (Gachotte et
al., 1996, Lichtenthaler, 1999). Finally, ergosterol biosynthesis is a very metabolically
taxing process that requires molecular oxygen, sources of energy, and optimal
temperatures (Parks & Casey, 1995). Despite these potential complications,
complementing the yeast ERG3 null mutation with the ERG3 gene from Chlamydomonas
reinhardtii allows for the production of ergosterol, and increased survival of the cells
during exposure to cycloheximide and growth on acetate.
Elucidation of the ergosterol biosynthetic pathway in Chlamydomonas reinhardtii
is of great importance. There continues to be an interest in plant and algal sterols for
commercial use as dietary supplements, and as components of cosmetics and
pharmaceuticals (Fernandes & Cabral, 2007). For example, experimental evidence has
shown that uptake of plant sterols can help to reduce cholesterol levels in humans
(Moghadasian & Frohlich, 1999, Tapiero et al., 2003). The similarity of the C.
reinhardtii ERG3 gene with that of higher plants indicates that the Chlamydomonas
system may provide an excellent model system in which to study plant sterol
biosynthesis. Better understanding of this pathway will lead to the development of
directed knockout mutant strains in Chlamydomonas that may allow for overproduction
of specific ergosterol precursors. Unlike crop plants, C. reinhardtii is relatively
inexpensive to grow and with the new innovations in photobioreactors, large cultivation
of algal lipids may begin to become more efficient. Although, this is the first work to
elucidate the molecular function of any ergosterol biosynthetic enzyme in C. reinhardtii,
further studies will hopefully uncover greater significance of this pathway in the
unicellular algal system.
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CHAPTER 5
CONCLUSIONS
5.1 Chlamydomonas reinhardtii Ergosterol Biosynthetic Genes
While research in the field of ergosterol biosynthesis in C. reinhardtii has been
dormant for over a decade, the genes involved in the pathway have now been fully
elucidated. Investigations of these genes have led to the discovery of two key genes,
CPI1 and CAS1(Chapter 3), that show similarities to the higher plant biosynthesis of
sterols. Bioinformatics data presented here support the idea that C. reinhardtii produces
cycloartenol as a precursor to ergosterol instead of lanosterol as seen in fungal species
like S. cerevisiae. EST data have provided the support to identify whether or not these
genes are expressed. In addition, many of these genes are expressed at reasonable levels
as evidenced by the Q-RT PCR data presented in Figures 3.17, 3.18, and 3.19. Even
though the presence of some of the genes, for example ERG9, is not strongly supported
by EST data, there is no evidence to dismiss their involvement in ergosterol biosynthesis.
Most of the sequences for these genes now have Accession numbers in the NCBI Pubmed
Database (Table 5.1). While the development of a model pathway for ergosterol
biosynthesis in C. reinhardtii was one of the major goals of this dissertation (Figure 3.2),
there is still a vast amount of work left to be done in order to begin to fully characterize
these genes and the enzymes for which they encode. Bioinformatics data gives valuable
information about the locations and putative functions of the proteins, but sufficient
experimental evidence is needed to confirm and characterize the function of each protein.
While sterol fluctuations have been implicated in the cell cycle (Janero et al.,
1982), there has not been a correlation shown between reflagellation and ergosterol
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biosynthesis until now. Innovations in molecular biology techniques have allowed the
perfection of quality Q-RT PCR analysis of genes in C. reinhardtii. Several key genes
(ERG3, ERG4, ERG5, ERG6, ERG7, ERG11) (Figure 3.18) in the ergosterol
biosynthetic pathway do show upregulation during reflagellation lending to the
hypothesis that in order to reflagellate the cell, new membranes must also be synthesized.
The previously documented ergosterol mutant (Bard et al., 1978), cc652, does show a
lack of expression of ERG5 (Figure 3.17), which completely supports the original data
from GC/MS profiles (Bard et al., 1978) regarding the absence of a C22-desaturase. In
addition, bald mutants also were analyzed by Q-RT PCR. This analysis, however,
provided no conclusive data (Figure 3.19) from the specific sterol genes implicationed in
the complete lack of flagella.
5.2 Chlamydomonas reinhardtii ERG3 Complements erg3Δ Yeast Mutants
The design of the working model for ergosterol biosynthesis in C. reinhardtii,
bioinformatics analysis and Q-RT analysis of the specific genes involved gave a unique
foundation by which I could then begin to analyze the genes by heterologous
complementation in yeast. Sterol biosynthesis is variable among eukaryotic species.
Higher plants metabolize squalene epoxide to cycloartenol to produce ergosterol as well
as other sterol molecules, while yeasts metabolize squalene epoxide to lanosterol (Figure
3.7). This variation in substrate specificity and product formation can often make
heterologous complementations with these genes quite difficult. The strategy for
approaching this potential problem was to choose several genes in the pathway to study.
ERG3 and ERG11 were both analyzed. While ERG11 in yeast catalyzes the substrate
lanosterol, while in higher plants the ERG11 ortholog CYP51G1 catalyzes the substrate
obtusifoliol. Heterologous complementation was unsuccessful due to high substrate
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specificity of the enzymes. Since ERG3 catalyzes the conversion of episterol to ergosta5,7,24(28)- trienol (Figure 4.1) in yeast and higher plants, this gene was a likely choice
for complementation. Several other genes of the pathway are homologous and did show
some sequence similarity, but their substrate specificities varied between higher plants
and yeast; the Erg3p specificity for episterol allowed the complementation to be a
success.
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Table 5.1. Gene names and NCBI Accession Numbers for Genes of the Ergosterol
Biosynthetic Pathway in C. reinhardtii. Higher plant nomenclature denoted in
parentheses.
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CHAPTER 6
FUTURE AND LONG RANGE SIGNIFICANCE OF THIS RESEARCH
Sterol biosynthesis has been studied for several decades and has been proven to
be at the pinnacle of some of the most important discoveries in science and medicine.
The longevity of this field of science is due in part to its complexity and interlocking
nature with so many other biochemical pathways. While basic sciences research has
provided us with several model systems to analyze sterols, the study of sterol
biosynthesis in C. reinhardtii is still in its infancy. The data presented in this dissertation
will hopefully open the door for future studies of sterol biosynthesis in C. reinhardtii.
Bioinformatics analysis provides the framework by which a putative pathway could be
designed for future testing. The use of heterologous complementation in yeast provided
me with the ability to test the function of ERG3 in C. reinhardtii. Quantitative RT PCR
analysis allowed a closer look at the regulation of these genes during reflagellation as
well as analysis of ergosterol genes in bald, flagella-less mutant strains of C. reinhardtii.
In spite of the experiments presented in this dissertation, there are still many
questions that have yet to be formulated and answered. Homologous recombination and
use of knockout technologies are just beginning to be perfected in C. reinhardtii. In years
to come, it may become increasingly easier to target specific genes of the ergosterol
pathway and measure its affects and study phenotypic changes. Sterol biosynthesis
intersects with so many other biochemical pathways, and it will be interesting in the
future to manipulate genes of the ergosterol pathway in order to overproduce other
phytosterols for hormone replacement therapies, natural birth control or even production
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of natural dietary supplements. While it has been found that plant sterols in the presence
of cholesterol precursors can put undue stress on the aortic valve (Helske et al., 2008),
better understanding of the genes of the pathway in this alga, may allow us to create
efficient synthetic, ingestible plant enzymes. These enzymes can be used to supplement
the sterol enzymes in humans that can degrade these arterial plaques due to their substrate
specificity of the cycloartenol precursors of the sterol pathway versus the more higher
eukaryotic lanosterol pathway.
Another potential manipulation of this pathway could lead to use of this model
system for biofuels production. While all of these future studies are quite intriguing,
scientists may argue of the cost effectiveness of mass-producing Chlamydomonas. With
the new wave towards producing a greener economy, I predict that in the next ten years,
scientists will develop functional economical photobioreactors that will be able to
generate algal biomass for fuel production with equal or lesser cost than our present
technologies in petroleum deep sea drilling rigs. These photobioreactors will be located
primarily in cities of high CO2 emission, next to some of our oil refineries and factories,
and in densely populated cities.
While basic sciences research has provided us with several model systems to
analyze sterols, the study of sterol biosynthesis in C. reinhardtii is still in its infancy. But
there is a vast interest in studying algal lipid biosynthesis for biofuels production. One
major example is Botryococcus braunii. This green photosynthetic algae is known for
making a vast array of hydrocarbons and methylated squalenes. Like C. reinhardtii, it
too primarily synthesizes its lipids by the DOXP pathway. Understanding the genes
involved in lipid biosynthesis may help to begin to identify specific precursors that can be
used as biofuels or other commercial products. Basic science research has been the
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foundation for some of the greatest innovations of our time. Specifically, sterol
biosynthesis has been implicated in several aspects of human disease from Alzheimer’s
disease to polycystic kidney disease. Because we now know the sterol components of the
flagella, there may be some future interest in monitoring the movement or production of
sterols in the whole cell to the flagella. GFP tagging is becoming a widespread technique
in C. reinhardtii. Tagging ergosterol biosynthetic genes to look at activity during
reflagellation may be a future experiment that may give greater detail as to whether or not
these genes play a role in the regrowth of the flagella. Recent flagella research focused
primarily on IFT proteins, but it is interesting to note that there are equal concentrations
of sterol in the whole cell and flagella according to Gealt et al. (Gealt et al., 1981). If we
presume that the ER is producing sterols that are transported from the whole cell
extending out to the flagella, one might agree that the sterols must be resynthesized
everytime flagella regenerate. This hypothesis supports the idea that ergosterol
biosynthetic genes have to turn on in order for membrane biogenesis of the flagella to
occur. If the flagellum has a very similar proportion of sterols compared to the whole
cell, then it would make sense that other lipid classes would be found in the flagellar
membranes, but according to the literature (Gealt et al., 1981) this is not the case. With
the knowledge that flagella is comprised primarily of sterol and fatty acid according to
Gealt et al. (Gealt et al., 1981), there must be some unique cellular process that allows
the flagellar membrane to exclude other lipid classes except sterols and fatty acids, and if
this is the case, I have provided evidence that ergosterol biosynthesis plays some role in
membrane biogenesis during reflagellation.
It is my hope that with new experimental technologies in C. reinhardtii, it will
become easier to study these questions of interest. The primary challenge for researchers
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in this field is the technology available to study these questions in this model system, but
it is my firm belief that as newer protocols are developed and successfully tested,
ergosterol biosynthetic studies in C. reinhardtii will arise as a very competitive field of
lipid research.
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